Publicacions en col·laboració amb investigadors/es de Hospital Universitario La Paz (67)

2024

  1. Evaluation of the transition from intravenous to subcutaneous vedolizumab in patients with inflammatory bowel disease

    Gastroenterologia y Hepatologia

  2. Human intestinal spirochetosis: an entity associated with sexual transmitted infections

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 5, pp. 231-235

  3. Intensification with Intravenous Ustekinumab in Refractory Crohn’s Disease

    Journal of Clinical Medicine, Vol. 13, Núm. 3

  4. Selective granulocyte–monocyte apheresis during induction with vedolizumab in moderate–severe ulcerative colitis: Experience in a tertiary hospital

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 7, pp. 721-726

  5. Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA

    Clinical Gastroenterology and Hepatology, Vol. 22, Núm. 11, pp. 2280-2290

2023

  1. Current management of bowel failure due to Crohn's disease in Spain: Results of a GETECCU survey

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 6, pp. 439-445

  2. Duodenal pyogenic granuloma: An unusual cause of chronic anemia

    Revista espanola de enfermedades digestivas, Vol. 115, Núm. 9, pp. 530-531

  3. Influence of biologic therapy on cardiovascular risk factors in patients with inflammatory bowel disease

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 2, pp. 109-115

  4. Randomized clinical trial evaluating three low-volume preparations for colonoscopy in outpatients with Inflammatory Bowel Disease: the EII-PREP trial

    Scandinavian Journal of Gastroenterology, Vol. 58, Núm. 6, pp. 656-663

  5. Serologic response to COVID-19 vaccines in patients with inflammatory bowel disease: a prospective study

    Revista Espanola de Enfermedades Digestivas, Vol. 115, Núm. 8, pp. 444-449

  6. Seroprevalence of ANTI-SARS-CoV-2 antibodies in patients with inflammatory bowel disease

    Scientific Reports, Vol. 13, Núm. 1

2022

  1. Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)

    Journal of Clinical Medicine

  2. Correlation between endoscopy and intestinal ultrasound for the evaluation of postoperative recurrence of Crohn's disease

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 1, pp. 40-46

  3. Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients

    Frontiers in Medicine, Vol. 9

  4. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  5. Nutricional habits in patients with inflammatory bowel disease: perception of patients and health professionals

    Gastroenterologia y Hepatologia, Vol. 45, pp. 2-3

2021

  1. Doppler Activity and Ultrasonographic Detection of Intra-Abdominal Fistulas Are Predictors of Surgery in Crohn's Disease

    Digestive Diseases, Vol. 39, Núm. 3, pp. 204-210

  2. Incidence, clinical characteristics and management of inflammatory bowel disease in spain: Large-scale epidemiological study

    Journal of Clinical Medicine, Vol. 10, Núm. 13

  3. Is the degree of i2a recurrence in Crohn's disease secondary to ischemic phenomena?

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 113, Núm. 4, pp. 246-250

  4. Optimization of azathioprine dose in combined treatment with anti-TNF-alpha in inflammatory bowel disease

    Gastroenterologia y Hepatologia, Vol. 44, Núm. 5, pp. 337-345